Market Overview

Elanco Animal Health Begins Trading After Eli Lilly Split

Elanco Animal Health Begins Trading After Eli Lilly Split

Elanco Animal Health Inc (NYSE: ELAN), a global animal health company, began trading Monday as a fully standalone entity after completing a split from Eli Lilly And Co (NYSE: LLY).

What Happened

Elanco completed its initial public offering in September 2018, at which point Eli Lilly was a majority shareholder with an 80.2-percent stake. In early February, the parent company said it would divest the remaining stake. Shareholders could exchange all, some or none of their Eli Lilly stock. The ultimate exchange ratio was settled at 4.5121 shares of Elanco common stock for each share of Eli Lilly common stock.

On Monday, Elanco officially completed its separation from Eli Lilly and traded as a standalone entity for the first time.

Why It's Important

The exchange offer was 7.6 times oversubscribed, which reflects the company's confidence that it has the "right strategy and [is] successfully progressing the execution against it," Elanco President and CEO Jeff Simmons said in a press release.

Since the 2018 IPO, Elanco has reported two full quarters of operating results, and the company ended 2018 with 6-percent revenue growth to $3.1 billion.

What's Next

"With this milestone behind us, we look forward to a singular focus delivering innovative solutions and services for our customers —the farmers, veterinarians and pet owners that are central to our success," Simmons said. 

Related Links:

Eli Lilly Gets Ready For First Report Post-Elanco IPO

40 Stocks Moving In Monday's Mid-Day Session

Posted-In: News Best of Benzinga


Related Articles (LLY + ELAN)

View Comments and Join the Discussion!
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

Stitch Fix Soars On Earnings Growth, Touts 3 Million Active Users

Norway's Wealth Fund To Dump Oil Producers